Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1395-1399
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thanopoulos, B. D.
Right arrow Articles by Zarayelyan, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thanopoulos, B. D.
Right arrow Articles by Zarayelyan, A. G.

CLINICAL STUDIES

Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children1

Basil (Vasilios) D. Thanopoulos, MDa, George S. Tsaousis, MDa, Georgia N. Konstadopoulou, MDa and Armine G. Zarayelyan, MDa

a Department of Pediatric Cardiology, "Aghia Sophia" Children’s Hospital, Athens, Greece

Manuscript received June 10, 1998; revised manuscript received November 20, 1998, accepted December 24, 1998.

Reprint requests and correspondence: Dr. Basil (Vasilios) D. Thanopoulos, Department of Pediatric Cardiology, "Aghia Sophia" Children’s Hospital, Thivon & Levadias Street, Athens 11527, Greece

OBJECTIVES

The aim of this study was to close muscular ventricular septal defects (MVSDs) in children, with a new device, the Amplatzer ventricular septal defect occluder (AVSDO).

BACKGROUND

The design of previously used devices for transcatheter closure of MVSDs is not ideal for this purpose and their use has been limited by several drawbacks.

METHODS

Six patients, aged 3 to 10 years, with MVSDs underwent transcatheter closure using the AVSDO. The device is a modified self-centering and repositionable Amplatzer device that consists of two low profile disks made of Nitinol wire mesh with a 7-mm connecting waist. The prosthesis size (connecting waist diameter) was chosen according to the measured balloon stretched VSD diameters. A 6-F or 7-F sheath was used for the delivery of the AVSDO. Fluoroscopy and transesophageal echocardiography were utilized for optimal guidance.

RESULTS

The location of the defect was midmuscular in five patients and beneath the pulmonary valve in one. The balloon stretched MVSD diameter ranged from 6 to 11 mm. Device placement was successful in all patients, and complete occlusion occurred in all six patients (95% confidence interval 54.06% to 100%). Two patients developed transient complete left bundle branch block. No other complications were observed.

CONCLUSIONS

This encouraging initial clinical success indicates that the AVSDO is a promising device for transcatheter closure of MVSDs in children. Further clinical trials and longer follow-up are needed before the widespread use of this technique can be recommended.

Abbreviations and Acronyms
  ASD = atrial septal defect
  MVSDs = muscular ventricular septal defects
  Qp/Qs = pulmonary/systemic flow ratio
  SPAP = systolic pulmonary artery pressure
  TEE = transesophageal echocardiography
  TGA = transposition of the great arteries




This article has been cited by other articles:


Home page
HeartHome page
A Wahl and B Meier
Patent foramen ovale and ventricular septal defect closure
Heart, January 1, 2009; 95(1): 70 - 82.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
Z. M. Hijazi and S. M. Awad
Pediatric Cardiac Interventions
J. Am. Coll. Cardiol. Intv., December 1, 2008; 1(6): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Szkutnik, S A Qureshi, J Kusa, E Rosenthal, and J Bialkowski
Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects
Heart, March 1, 2007; 93(3): 355 - 358.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Butera, M. Carminati, M. Chessa, L. Piazza, R. Abella, D. G. Negura, A. Giamberti, B. Claudio, A. Micheletti, Y. Tammam, et al.
Percutaneous closure of ventricular septal defects in children aged <12: early and mid-term results
Eur. Heart J., December 1, 2006; 27(23): 2889 - 2895.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Rabenstein, C. Boosfeld, R. Henrich, and C. Ell
First use of ventricular septal defect occlusion device for endoscopic closure of an esophagorespiratory fistula using bronchoscopy and esophagoscopy.
Chest, September 1, 2006; 130(3): 906 - 909.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B D Thanopoulos and M L Rigby
Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder
Heart, April 1, 2005; 91(4): 513 - 516.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J.-F. Piechaud
Closing down: transcatheter closure of intracardiac defects and vessel embolisations
Heart, December 1, 2004; 90(12): 1505 - 1510.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Holzer, D. Balzer, Q.-L. Cao, K. Lock, Z. M. Hijazi, and Amplatzer Muscular Ventricular Septal Defect Inves
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1257 - 1263.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B D Thanopoulos, G S Tsaousis, E Karanasios, N G Eleftherakis, and C Paphitis
Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children
Heart, August 1, 2003; 89(8): 918 - 922.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B D Thanopoulos, G S Tsaousis, M Djukic, F Al Hakim, N G Eleftherakis, and S D Simeunovic
Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder
Heart, March 1, 2002; 87(3): 260 - 263.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M L Rigby
Transoesophageal echocardiography during interventional cardiac catheterisation in congenital heart disease
Heart, December 1, 2001; 86(90002): ii23 - 29.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Okubo, L. N. Benson, D. Nykanen, A. Azakie, G. Van Arsdell, J. Coles, and W. G. Williams
Outcomes of intraoperative device closure of muscular ventricular septal defects
Ann. Thorac. Surg., August 1, 2001; 72(2): 416 - 423.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. A. Pigula, P. Buenaventura, J. A. Ettedgui, and R. D. Siewers
Management of retroperitoneal arterial injury after heart catheterization in children
Ann. Thorac. Surg., May 1, 2000; 69(5): 1582 - 1584.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement